KDR and glioblastoma: We reported translational research of berberine in glioblastoma therapy, and proved inhibitory activity of berberine on angiogenesis in both cell-based assays and mouse xenograft model of human glioblastoma, as well as clarified involved VEGFR2/ERK pathway.